The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Specialty Pharmaceutical-Global Market Insights and Sales Trends 2024
Synopsis
Specialty pharmaceuticals are a recent designation of pharmaceuticals that are classified as high-cost, high complexity and/or high touch.
The global Specialty Pharmaceutical market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Specialty Pharmaceutical in various end use industries. The expanding demands from the Tumor, Diabetes, Cardiovascular and Hemophilia, are propelling Specialty Pharmaceutical market. Antibody, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Hormone segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Specialty Pharmaceutical, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Specialty Pharmaceutical market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Specialty Pharmaceutical market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Specialty Pharmaceutical sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Specialty Pharmaceutical covered in this report include Pfizer, Roche, Amgen, AbbVie, Novo Nordisk, Johnson & Johnson, Sanofi-Aventis, Merck and Eli Lilly, etc.
The global Specialty Pharmaceutical market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Roche
Amgen
AbbVie
Novo Nordisk
Johnson & Johnson
Sanofi-Aventis
Merck
Eli Lilly
Novartis
3sbio
Changchun High Tech
CP Guojian Pharmacy
Biotech Pharma
Gelgen Biopharma
Innovent
Global Specialty Pharmaceutical market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Specialty Pharmaceutical market, Segment by Type:
Antibody
Hormone
Growth Factors
Other
Global Specialty Pharmaceutical market, by Application
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Specialty Pharmaceutical companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Specialty pharmaceuticals are a recent designation of pharmaceuticals that are classified as high-cost, high complexity and/or high touch.
The global Specialty Pharmaceutical market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Specialty Pharmaceutical in various end use industries. The expanding demands from the Tumor, Diabetes, Cardiovascular and Hemophilia, are propelling Specialty Pharmaceutical market. Antibody, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Hormone segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Specialty Pharmaceutical, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Specialty Pharmaceutical market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Specialty Pharmaceutical market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Specialty Pharmaceutical sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Specialty Pharmaceutical covered in this report include Pfizer, Roche, Amgen, AbbVie, Novo Nordisk, Johnson & Johnson, Sanofi-Aventis, Merck and Eli Lilly, etc.
The global Specialty Pharmaceutical market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Roche
Amgen
AbbVie
Novo Nordisk
Johnson & Johnson
Sanofi-Aventis
Merck
Eli Lilly
Novartis
3sbio
Changchun High Tech
CP Guojian Pharmacy
Biotech Pharma
Gelgen Biopharma
Innovent
Global Specialty Pharmaceutical market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Specialty Pharmaceutical market, Segment by Type:
Antibody
Hormone
Growth Factors
Other
Global Specialty Pharmaceutical market, by Application
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Specialty Pharmaceutical companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Specialty Pharmaceutical
1.1 Specialty Pharmaceutical Market Overview
1.1.1 Specialty Pharmaceutical Product Scope
1.1.2 Specialty Pharmaceutical Market Status and Outlook
1.2 Global Specialty Pharmaceutical Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Specialty Pharmaceutical Market Size by Region (2018-2029)
1.4 Global Specialty Pharmaceutical Historic Market Size by Region (2018-2023)
1.5 Global Specialty Pharmaceutical Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Specialty Pharmaceutical Market Size (2018-2029)
1.6.1 North America Specialty Pharmaceutical Market Size (2018-2029)
1.6.2 Europe Specialty Pharmaceutical Market Size (2018-2029)
1.6.3 Asia-Pacific Specialty Pharmaceutical Market Size (2018-2029)
1.6.4 Latin America Specialty Pharmaceutical Market Size (2018-2029)
1.6.5 Middle East & Africa Specialty Pharmaceutical Market Size (2018-2029)
2 Specialty Pharmaceutical Market by Type
2.1 Introduction
2.1.1 Antibody
2.1.2 Hormone
2.1.3 Growth Factors
2.1.4 Other
2.2 Global Specialty Pharmaceutical Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Specialty Pharmaceutical Historic Market Size by Type (2018-2023)
2.2.2 Global Specialty Pharmaceutical Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Specialty Pharmaceutical Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Specialty Pharmaceutical Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Specialty Pharmaceutical Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Specialty Pharmaceutical Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Specialty Pharmaceutical Revenue Breakdown by Type (2018-2029)
3 Specialty Pharmaceutical Market Overview by Application
3.1 Introduction
3.1.1 Tumor
3.1.2 Diabetes
3.1.3 Cardiovascular
3.1.4 Hemophilia
3.1.5 Other
3.2 Global Specialty Pharmaceutical Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Specialty Pharmaceutical Historic Market Size by Application (2018-2023)
3.2.2 Global Specialty Pharmaceutical Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Specialty Pharmaceutical Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Specialty Pharmaceutical Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Specialty Pharmaceutical Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Specialty Pharmaceutical Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Specialty Pharmaceutical Revenue Breakdown by Application (2018-2029)
4 Specialty Pharmaceutical Competition Analysis by Players
4.1 Global Specialty Pharmaceutical Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Specialty Pharmaceutical as of 2022)
4.3 Date of Key Players Enter into Specialty Pharmaceutical Market
4.4 Global Top Players Specialty Pharmaceutical Headquarters and Area Served
4.5 Key Players Specialty Pharmaceutical Product Solution and Service
4.6 Competitive Status
4.6.1 Specialty Pharmaceutical Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business
5.1.3 Pfizer Specialty Pharmaceutical Products, Services and Solutions
5.1.4 Pfizer Specialty Pharmaceutical Revenue (US$ Million) & (2018-2023)
5.1.5 Pfizer Recent Developments
5.2 Roche
5.2.1 Roche Profile
5.2.2 Roche Main Business
5.2.3 Roche Specialty Pharmaceutical Products, Services and Solutions
5.2.4 Roche Specialty Pharmaceutical Revenue (US$ Million) & (2018-2023)
5.2.5 Roche Recent Developments
5.3 Amgen
5.3.1 Amgen Profile
5.3.2 Amgen Main Business
5.3.3 Amgen Specialty Pharmaceutical Products, Services and Solutions
5.3.4 Amgen Specialty Pharmaceutical Revenue (US$ Million) & (2018-2023)
5.3.5 AbbVie Recent Developments
5.4 AbbVie
5.4.1 AbbVie Profile
5.4.2 AbbVie Main Business
5.4.3 AbbVie Specialty Pharmaceutical Products, Services and Solutions
5.4.4 AbbVie Specialty Pharmaceutical Revenue (US$ Million) & (2018-2023)
5.4.5 AbbVie Recent Developments
5.5 Novo Nordisk
5.5.1 Novo Nordisk Profile
5.5.2 Novo Nordisk Main Business
5.5.3 Novo Nordisk Specialty Pharmaceutical Products, Services and Solutions
5.5.4 Novo Nordisk Specialty Pharmaceutical Revenue (US$ Million) & (2018-2023)
5.5.5 Novo Nordisk Recent Developments
5.6 Johnson & Johnson
5.6.1 Johnson & Johnson Profile
5.6.2 Johnson & Johnson Main Business
5.6.3 Johnson & Johnson Specialty Pharmaceutical Products, Services and Solutions
5.6.4 Johnson & Johnson Specialty Pharmaceutical Revenue (US$ Million) & (2018-2023)
5.6.5 Johnson & Johnson Recent Developments
5.7 Sanofi-Aventis
5.7.1 Sanofi-Aventis Profile
5.7.2 Sanofi-Aventis Main Business
5.7.3 Sanofi-Aventis Specialty Pharmaceutical Products, Services and Solutions
5.7.4 Sanofi-Aventis Specialty Pharmaceutical Revenue (US$ Million) & (2018-2023)
5.7.5 Sanofi-Aventis Recent Developments
5.8 Merck
5.8.1 Merck Profile
5.8.2 Merck Main Business
5.8.3 Merck Specialty Pharmaceutical Products, Services and Solutions
5.8.4 Merck Specialty Pharmaceutical Revenue (US$ Million) & (2018-2023)
5.8.5 Merck Recent Developments
5.9 Eli Lilly
5.9.1 Eli Lilly Profile
5.9.2 Eli Lilly Main Business
5.9.3 Eli Lilly Specialty Pharmaceutical Products, Services and Solutions
5.9.4 Eli Lilly Specialty Pharmaceutical Revenue (US$ Million) & (2018-2023)
5.9.5 Eli Lilly Recent Developments
5.10 Novartis
5.10.1 Novartis Profile
5.10.2 Novartis Main Business
5.10.3 Novartis Specialty Pharmaceutical Products, Services and Solutions
5.10.4 Novartis Specialty Pharmaceutical Revenue (US$ Million) & (2018-2023)
5.10.5 Novartis Recent Developments
5.11 3sbio
5.11.1 3sbio Profile
5.11.2 3sbio Main Business
5.11.3 3sbio Specialty Pharmaceutical Products, Services and Solutions
5.11.4 3sbio Specialty Pharmaceutical Revenue (US$ Million) & (2018-2023)
5.11.5 3sbio Recent Developments
5.12 Changchun High Tech
5.12.1 Changchun High Tech Profile
5.12.2 Changchun High Tech Main Business
5.12.3 Changchun High Tech Specialty Pharmaceutical Products, Services and Solutions
5.12.4 Changchun High Tech Specialty Pharmaceutical Revenue (US$ Million) & (2018-2023)
5.12.5 Changchun High Tech Recent Developments
5.13 CP Guojian Pharmacy
5.13.1 CP Guojian Pharmacy Profile
5.13.2 CP Guojian Pharmacy Main Business
5.13.3 CP Guojian Pharmacy Specialty Pharmaceutical Products, Services and Solutions
5.13.4 CP Guojian Pharmacy Specialty Pharmaceutical Revenue (US$ Million) & (2018-2023)
5.13.5 CP Guojian Pharmacy Recent Developments
5.14 Biotech Pharma
5.14.1 Biotech Pharma Profile
5.14.2 Biotech Pharma Main Business
5.14.3 Biotech Pharma Specialty Pharmaceutical Products, Services and Solutions
5.14.4 Biotech Pharma Specialty Pharmaceutical Revenue (US$ Million) & (2018-2023)
5.14.5 Biotech Pharma Recent Developments
5.15 Gelgen Biopharma
5.15.1 Gelgen Biopharma Profile
5.15.2 Gelgen Biopharma Main Business
5.15.3 Gelgen Biopharma Specialty Pharmaceutical Products, Services and Solutions
5.15.4 Gelgen Biopharma Specialty Pharmaceutical Revenue (US$ Million) & (2018-2023)
5.15.5 Gelgen Biopharma Recent Developments
5.16 Innovent
5.16.1 Innovent Profile
5.16.2 Innovent Main Business
5.16.3 Innovent Specialty Pharmaceutical Products, Services and Solutions
5.16.4 Innovent Specialty Pharmaceutical Revenue (US$ Million) & (2018-2023)
5.16.5 Innovent Recent Developments
6 North America
6.1 North America Specialty Pharmaceutical Market Size by Country (2018-2029)
6.2 the United States
6.3 Canada
7 Europe
7.1 Europe Specialty Pharmaceutical Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Specialty Pharmaceutical Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Specialty Pharmaceutical Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Specialty Pharmaceutical Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Specialty Pharmaceutical Market Dynamics
11.1 Specialty Pharmaceutical Industry Trends
11.2 Specialty Pharmaceutical Market Drivers
11.3 Specialty Pharmaceutical Market Challenges
11.4 Specialty Pharmaceutical Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
